Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS

Zyesami inhalation (aviptadil) - Relief Therap, United Therapeutics Corp, Seren Clinical, NRx Pharma

http://clinicaltrials.gov/ct2/show/NCT04536350

Jan 18, 2024